GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » E10

Willow Biosciences (TSX:WLLW) E10 : C$-3.69 (As of Sep. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Willow Biosciences's adjusted earnings per share data for the three months ended in Sep. 2024 was C$-0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-3.69 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 49.10% per year. During the past 5 years, the average E10 Growth Rate was 42.10% per year. During the past 10 years, the average E10 Growth Rate was 28.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Willow Biosciences was 49.10% per year. The lowest was -3.00% per year. And the median was 15.30% per year.

As of today (2025-03-17), Willow Biosciences's current stock price is C$0.04. Willow Biosciences's E10 for the quarter that ended in Sep. 2024 was C$-3.69. Willow Biosciences's Shiller PE Ratio of today is .


Willow Biosciences E10 Historical Data

The historical data trend for Willow Biosciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences E10 Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -77.30 -48.91 -26.12 -21.55 -6.46

Willow Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.24 -6.46 -5.95 -4.28 -3.69

Competitive Comparison of Willow Biosciences's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Willow Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Willow Biosciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Willow Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Willow Biosciences's Shiller PE Ratio falls into.



Willow Biosciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Willow Biosciences's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.01/127.2847*127.2847
=-0.010

Current CPI (Sep. 2024) = 127.2847.

Willow Biosciences Quarterly Data

per share eps CPI Adj_EPS
201412 -2.000 98.367 -2.588
201503 -2.000 99.789 -2.551
201506 -2.500 100.500 -3.166
201509 -1.500 100.421 -1.901
201512 -2.000 99.947 -2.547
201603 -1.125 101.054 -1.417
201606 -5.425 102.002 -6.770
201609 -1.250 101.765 -1.563
201612 -0.500 101.449 -0.627
201703 -0.750 102.634 -0.930
201706 -5.750 103.029 -7.104
201709 -0.750 103.345 -0.924
201712 -0.250 103.345 -0.308
201803 -0.750 105.004 -0.909
201806 -0.750 105.557 -0.904
201809 -0.250 105.636 -0.301
201812 -0.250 105.399 -0.302
201903 -0.500 106.979 -0.595
201906 -0.560 107.690 -0.662
201909 -0.010 107.611 -0.012
201912 -0.030 107.769 -0.035
202003 -0.020 107.927 -0.024
202006 -0.130 108.401 -0.153
202009 -0.100 108.164 -0.118
202012 -0.170 108.559 -0.199
202103 -0.100 110.298 -0.115
202106 0.050 111.720 0.057
202109 0.030 112.905 0.034
202112 -0.040 113.774 -0.045
202203 -0.020 117.646 -0.022
202206 -0.030 120.806 -0.032
202209 -0.030 120.648 -0.032
202212 -0.040 120.964 -0.042
202303 -0.040 122.702 -0.041
202306 -0.030 124.203 -0.031
202309 -0.020 125.230 -0.020
202312 -0.010 125.072 -0.010
202403 -0.020 126.258 -0.020
202406 -0.010 127.522 -0.010
202409 -0.010 127.285 -0.010

Add all the adjusted EPS together and divide 10 will get our e10.


Willow Biosciences  (TSX:WLLW) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Willow Biosciences E10 Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Willow Biosciences Business Description

Traded in Other Exchanges
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.
Executives
Christopher Kenneth Savile Director, Senior Officer
Travis Doupe Senior Officer
Patricia Ranija Choudhary Director
Sadiq Lalani Director
Barbara Elaine Munroe Director
Peter Seufer-wasserthal Director
Trevor Anthony Peters Director, Senior Officer
Troy Tapan Talkkari Senior Officer

Willow Biosciences Headlines

No Headlines